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Abstract 
Objectives: The purpose of this study was to conduct the first randomised controlled trial to 
evaluate the effectiveness of a second-generation mindfulness-based intervention (SG-MBI) 
for treating fibromyalgia syndrome (FMS). Compared to first-generation mindfulness-based 
interventions, SG-MBIs are more acknowledging of the spiritual aspect of mindfulness. 
Design: A randomised controlled trial employing intent-to-treat analysis. 
Methods: Adults with FMS received an eight-week SG-MBI known as Meditation 
Awareness Training (MAT; n = 74) or an active control intervention known as Cognitive-
Behaviour Therapy for Groups (n = 74). Assessments were performed at pre-, post-, and six-
month follow-up phases.  
Results: MAT participants demonstrated significant and sustained improvements over 
control-group participants in FMS symptomatology, pain perception, sleep quality, 
psychological distress, non-attachment (to self, symptoms, and environment), and civic 
engagement. A mediation analysis found that (i) civic engagement partially mediated 
treatment effects for all outcome variables, (ii) non-attachment partially mediated treatment 
effects for psychological distress and sleep quality, and (iii) non-attachment almost fully 
mediated treatment effects for FMS symptomatology and pain perception. Average daily time 
spent in meditation was found to be a significant predictor of changes in all outcome 
variables. 
Conclusions: MAT may be a suitable treatment for adults with FMS and appears to 
ameliorate FMS symptomatology and pain perception by reducing attachment to self.  
 
Keywords: Fibromyalgia Syndrome, Pain Disorder, Meditation Awareness Training, 
Mindfulness, Second-Generation Mindfulness-Based Interventions, Spirituality 
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Introduction 
Fibromyalgia syndrome (FMS) is a chronic pain disorder that affects approximately 3% of 
adults, with higher rates of occurrence in females compared to males (Branco et al., 2010). 
Individuals with FMS typically experience symptoms of widespread musculoskeletal pain, 
sleep disturbance, poor quality of life, cognitive dysfunction (particularly memory 
impairment), psychological distress (i.e., depression, anxiety, and stress), and fatigue 
(Häuser, Wolfe, Tölle, Üçeyler, & Sommer, 2012; Jones, Sherman, Mist, Carson, Bennett, & 
Li, 2012; Wolfe, Brähler, Hinz, & Häuser, 2013). The condition is also associated with (i) 
high rates of presenting at medical services (Schaefer et al., 2011), unemployment (Scott & 
Jones, 2014), (ii) use of incapacity for work and/or disability benefits (Sicras-Mainar et al., 
2009; Wolfe et al., 1997), (iii) hypochondriasis, self-preoccupation and self-attachment 
(Canzonieri, Pollak, Oliveira, Costa, & Natour, 2013; Van Gordon, Shonin, & Griffiths, 
2016a; Wolfe, 2009), and (iv) low levels of civic engagement (Van Gordon et al., 2016a). 
There is no reliable laboratory test for FMS and diagnosis is often based on the 
exclusion of other pathologies as well as the patient’s verbal responses to gentle manual 
pressure being applied to tender body points (Van Gordon et al., 2016a). While some FMS 
patients appear to respond favourably to pharmacological treatments (principally tricyclic 
antidepressants and serotonin-norepinephrine reuptake inhibitors), many experience limited 
symptom reduction as well as adverse effects (Häuser et al., 2012; Luciano et al., 2016; 
Nüesch, Häuser, Bernardy, Barth, & Jüni, 2013). Consequently, an integrative treatment 
approach is currently preferred whereby pharmacological treatments are combined with (for 
example) aerobic exercise, cognitive-behavioural therapy, self-help, and/or psycho-education 
(Van Gordon et al., 2016a). 
The need for more efficacious FMS treatments – including those without the side-
effects of pharmacotherapy – has prompted a growth of scientific investigation into the 
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applications of mindfulness for treating FMS (Langhorst, Klose, Dobos, Bernardy, & Häuser, 
2013; Modrego, Morillo, López Montoyo, Correa, Borao, & García-Campayo, 2016). 
Mindfulness derives from Buddhist practice and is concerned with focusing awareness on 
moment-to-moment sensory and psychological experience (Garcia-Martin et al., 2016). The 
practice is understood to increase perceptual distance from distressing sensory and 
psychological stimuli, and this objectification of pain helps to regulate its impact on 
psychosocial functioning (Morone, Lynch, Greco, Tindle & Weiner, 2008; Van Gordon et al., 
2016a). 
Until recently, the healthcare literature has predominantly focused on what have been 
termed first-generation mindfulness-based interventions (FG-MBIs). The two most 
empirically investigated FG-MBIs are Mindfulness-Based Stress Reduction (Kabat-Zinn, 
1990) and Mindfulness-Based Cognitive Therapy (Segal, Williams, & Teasdale, 2002). 
Findings from FG-MBI studies indicate that they may have applications in the treatment of 
FMS. For example, a meta-analysis (n = 674) – incorporating six randomised controlled trials 
(RCTs) of MBSR – concluded that it led to short-term improvements in quality of life and 
pain compared to treatment-as-usual or active control groups (Lauche, Cramer, Dobos, 
Langhorst, & Schmidt, 2013). A more recent review study (n = 702; 10 RCTs, prospective or 
retrospective studies) that included a greater range of FG-MBIs (i.e., in addition to MBSR) 
reported mild-to-moderate treatment effects (Henke & Chur-Hansen, 2014). These findings 
are consistent with a meta-analysis (comprising nine RCTs with active control groups) in 
which effect sizes in the mild-to-moderate range were reported for the effectiveness of FG-
MBIs in the treatment of chronic pain (Cohen’s d = 0.33; Goyal et al., 2014). 
Second-generation mindfulness-based interventions (SG-MBIs) reflect a new 
direction in mindfulness research and practice and have been formulated in order to address 
some of the limitations of FG-MBIs. SG-MBIs differ from FG-MBIs by adopting a broader 
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definition of mindfulness that is more acknowledging of its spiritual roots. For example, an 
established FG-MBI definition of mindfulness was proposed by Kabat-Zinn who defined it as 
“paying attention in a particular way: on purpose, in the present moment, and non-
judgmentally” (1994, p.4). This definition frames mindfulness as a predominantly attentional 
process and is therefore arguably less encompassing than a recently proposed SG-MBI 
definition in which mindfulness was deemed to be “the process of engaging a full, direct, and 
active awareness of experienced phenomena that is (i) spiritual in aspect and, (ii) maintained 
from one moment to the next” (Shonin & Van Gordon, 2015, p. 900). 
In addition to being overtly spiritual in nature, SG-MBIs are distinct from FG-MBIs 
due to them employing (i) a greater range of meditative techniques (generally delivered in a 
secular context), (ii) ethics as a key component of the taught programme, and (iii) an 
instructor training programme that typically requires several years of supervised mindfulness 
practice (Van Gordon, Shonin, & Griffiths, 2015). Some SG-MBIs also introduce participants 
to meditative concepts such as impermanence, interconnectedness, non-self or emptiness, and 
non-attachment (Shonin & Van Gordon, 2015). The introduction of the non-attachment 
principle is based on the Buddhist view that suffering arises as a result of an individual’s 
‘attachment’ to both themselves and external phenomena (e.g., wealth, people, reputation, 
etc.; Feliu-Soler et al., 2016). The Buddhist notion of attachment has been defined as “the 
over-allocation of cognitive and emotional resources towards a particular object, construct, 
or idea to the extent that the object is assigned an attractive quality that is unrealistic and 
that exceeds its intrinsic worth” (Shonin, Van Gordon, & Griffiths, 2014a, p.126). 
Consequently, in the traditional meditation literature, reducing attachment (or augmenting 
non-attachment) is deemed to be an important feature of the path to psycho-spiritual 
wellbeing. Furthermore, given that self-attachment is deemed to play a role in the 
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maintenance of FMS (Van Gordon et al., 2016a), FMS interventions that specifically aim to 
reduce attachment (to self, symptoms, and environment) warrant empirical investigation. 
A positive association has been observed between spirituality and positive affect in 
individuals with FMS (Moreira-Almeida & Koenig, 2008). Consistent with this finding, 
qualitative studies of SG-MBIs have demonstrated that participants of both healthy and 
clinical status attribute improvements in health outcomes to increased spiritual awareness. 
Although a study investigating the effectiveness of an SG-MBI for treating FMS has not been 
conducted to date, SG-MBIs have demonstrable applications for treating many of the 
individual symptoms of FMS including (for example) psychological distress (Van Gordon, 
Shonin, Sumich, Sundin, & Griffiths, 2014), self-preoccupation and maladaptive ego-
constructs (Shonin, Van Gordon, & Griffiths, 2014b; Shonin & Van Gordon, 2015), and sleep 
disturbance (Van Gordon, Shonin, & Griffiths, 2016b). Using these findings as a basis, the 
purpose of the present RCT was to address the need for a rigorous empirical assessment of 
the effectiveness of an SG-MBI for treating FMS. Primary outcomes were fibromyalgia 
symptomatology, pain perception, sleep quality, and psychological distress. Secondary 
outcomes were non-attachment and civic engagement.   
 
Method 
Design 
An RCT (trial no.  NCT02800720) compared MAT with a purpose-designed active control 
condition. Consolidated Standards of Reporting Trials (CONSORT; Boutron, Altman, 
Schulz, & Ravaud, 2008; Schulz, Altman, & Moher, 2010) guidelines for non-
pharmacological interventions were followed where applicable. The trial was approved by the 
research team’s University Ethics Committee. A qualitative study exploring participant’s 
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experiences and general feasibility was embedded in the RCT, and findings from the 
qualitative study are reported elsewhere (see Van Gordon et al., 2016a). 
 
Participants 
Participants were male and female English-speaking adults with a current diagnosis of FMS 
(as confirmed by a letter from a general practitioner [GP], rheumatologist, or hospital pain 
consultant). Participation was on a voluntary basis and individuals were recruited via talks at 
FMS self-help groups, posters in GP surgeries, and emails sent to members of FMS support 
groups. Furthermore, some East-Midlands GPs were made aware of the study and were asked 
to informally raise awareness amongst relevant service users by suggesting that they could 
contact the research team for further information. 
As part of the informed consent process, participants were required to acknowledge 
that they understood that MAT (i) is deemed by its founders to be both a psychological and 
spiritual intervention, (ii) is not intended to be a course on Buddhism (i.e., it is secular in 
context) but makes extensive use of Buddhist meditative techniques and principles, and (iii) 
was founded by two Western psychologists who are also Buddhist monks. This step was 
implemented for ethical and transparency reasons on account of the fact that some FG-MBIs 
have been criticised for emphasising or masking their affiliation with Buddhism to suit their 
needs (Purser, 2015).  
 
Eligibility Criteria 
In addition to a current FMS diagnosis, the eligibility criteria for participation in the study 
were: (i) being aged between 18 and 65 years, (ii) being able to read and write using the 
English language, (iii) not currently undergoing formal psychotherapy, (iv) no changes in 
psychopharmacology type or dosage one-month prior to intervention (although stable 
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prescription medication was permitted), and (v) not currently practicing mindfulness or 
meditation. Participants were also required to confirm their availability to complete an eight-
week intervention and six-month follow-up assessment. Attendance at at-least seven of the 
eight weekly sessions is a prerequisite for course completion. In the current study, 
participants that did not attend the requisite number of sessions were classed as having 
dropped-out and were excluded from (or where unavailable to attend) future assessment 
phases. Participants were informed about the attendance requirements via the informed 
consent procedure.  
 
Randomisation and Blinding 
The first author (and principal investigator) was responsible for recruitment and participant 
screening. Following the screening process, eligible participants were assigned five-digit 
pseudonyms. The document linking participant demographic data and screening results to 
their pseudonyms was stored in a sealed opaque envelope in a lockable unit within the office 
of the principal investigator, and all other researchers were blinded as to its contents. A list of 
eligible participant pseudonyms, grouped by sex, was then passed to the second author who 
conducted the randomisation procedure (the principal investigator was not involved in the 
randomisation process). On a sex-strata basis, participant pseudonyms were placed into a 
bowl and then selected one at a time prior to being placed, in alternating sequence, into one 
of two separate envelopes corresponding to the intervention and control group (participants 
were grouped by sex in order to yield sex-matched intervention and control groups). 
Randomisation was implemented prior to administering baseline psychometric tests in order 
to facilitate the blinding of researchers involved in conducting the randomisation procedure. 
Participants were blinded as to allocation condition until after completion of baseline 
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assessments and were likewise blinded as to which allocation condition featured the target 
intervention. 
 
Sample Size Calculation 
Based on an equal distribution between allocation conditions, statistical power calculations 
using GPOWER Software (Faul & Erdinger, 1992) indicated a total sample size of 128 
participants would be required for an effect size of 0.5, an alpha of 0.05, and 80% power. 
Consistent with literature reviews conducted by other authors (e.g., Glombiewski, Sawyer, 
Gutermann, Koenig, Rief, & Hofmann, 2010), a comprehensive literature review conducted 
by the present authors found that an effect size of 0.5 appears to be standard for efficacy 
studies of mindfulness-based interventions as well as FMS treatment studies. The power 
calculation was conducted with the primary outcome measures in mind. An over-recruitment 
margin of 20 participants was applied to account for drop out. 
 
Programme Description 
MAT is an eight-week SG-MBI in which mindfulness is an integral component, but is not the 
exclusive focus (Shonin, Van Gordon, & Griffiths, 2014b; Van Gordon et al., 2014). The 
intervention is delivered by instructors who have undergone a three-year supervised MAT 
training programme. Participants attend eight weekly workshops (each lasting two hours) and 
receive a CD of guided meditations to facilitate daily self-practice. The weekly sessions 
comprise three distinct phases: (i) a taught/presentation component (approximately 45 
minutes), (ii) a facilitated group-discussion component (approximately 35 minutes), and (iii) 
guided meditation and/or mindfulness exercises (approximately 30 minutes). A 10-minute 
break is scheduled prior to commencing the guided meditation exercises. In the third and 
eighth week of the programme, participants attend one-to-one support sessions (each of 50-
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minutes duration) with the programme instructor (for comprehensive information regarding 
the intervention protocol, see Van Gordon et al., 2014). 
Due to the fact that individuals with FMS can experience difficulties in concentrating 
(referred to as ‘fibro fog’; Mease et al., 2008), in the present study the intervention was 
slightly modified to include an additional 5-minute break that occurred 45 minutes into the 
session (this was achieved by reducing the duration of the facilitated group discussion 
component to 30 minutes). In order to directly target the key symptoms and correlates of 
FMS, the intervention was also modified in the present study to include an extended focus on: 
(i) mindfulness techniques specifically concerned with meditatively observing and 
objectifying somatic pain, (ii) compassion meditation in order to help participants become 
less preoccupied with their illness (i.e., by becoming more aware of the suffering of others), 
and (iii) ‘engaged mindfulness’ (a technique intended to raise participants’ awareness of the 
benefits – to both themselves and others – of contributing to the welfare of society in a 
manner that does not exceed the physical and/or psychological demands of their condition). 
 Rather than prescribe a fixed amount of daily meditation practice time, participants 
are encouraged to adopt a dynamic meditation routine and are guided on an individual basis 
to find the optimum frequency and duration of meditation sessions. According to Van Gordon 
et al (2014), this avoids divisions being formed between formal seated meditation sessions 
and meditation during everyday life activities. In the present study, MAT was delivered by 
the second author (30 years meditation teaching experience) and the first author provided 
supervision in order to identify any deviations from the standard intervention delivery format. 
Supervision was implemented by the first author (i) silently observing at least 15 minutes of 
each weekly session (not always following the same amount of elapsed time into the 2-hour 
session), and (ii) engaging in discussion with the program facilitator on a weekly basis. With 
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the exception of the planned modifications specified above, no other deviations from the 
standard protocol were identified. 
MAT (and the control intervention) were delivered across multiple sites in the East 
Midlands in separate training rooms utilised by a meditation centre and GP surgery. Other 
than an over-head projector, chairs and tables, a singing bowl for use during the guided 
meditations, and sufficient space to practice walking meditation (that requires participants to 
walk in single file), no special equipment or arrangements were required. In the present 
study, the intervention was delivered using group-sizes of approximately 25 participants. 
 
Control Condition 
Cognitive Behavioural Theory for Groups (CBTG) is a purpose-designed control intervention 
formulated by Shonin, Van Gordon, Dunn, Singh, & Griffiths (2014c). CBTG is based on 
guidelines by MacCoon et al. (2012) for the development of suitable control groups for 
studies of mindfulness-based interventions (MBIs). CBTG involves educating participants in 
cognitive-behavioural theory and principles. It is identical to the intervention condition on all 
non-specific factors such as overall course length, individual session duration, group and one-
to-one discussion component, group-size, and inclusion of an at-home practice element. 
Weekly sessions comprise: (i) a taught presentation component (45 minutes), (ii) a facilitated 
group discussion component (30-minutes duration in the present study), (iii) guided discovery 
educational exercises (30 minutes), and (iv) the same number and duration of breaks as the 
target intervention. The weekly sessions are explicitly education-focused and do not include 
any practice or discussion of meditation.  
To control for a facilitator effect and ensure consistency of didactic style, CBTG was 
delivered by the same instructor who facilitated the MAT programme. To assess for 
differences in the instructor’s levels of enthusiasm between groups, participants in both the 
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intervention and control groups were asked to rate (on a 1 to 5 Likert scale) the instructor’s 
levels of planning and motivation. As with the target intervention, the CBTG sessions were 
supervised to identify any deviations from the standard intervention delivery format. With the 
exception of an additional 5-minute break that was introduced in order to match the target 
intervention, there were no planned or unplanned modifications to the delivery of CBTG. 
 
Outcome Measures 
Study outcomes were assessed via the following well-established psychometric scales: 
Revised Fibromyalgia Impact Questionnaire (FIQ-R; Bennett, Friend, Jones, Ward, Han, & 
Ross; 2009): The FIQ-R assesses the impact of FMS across the three domains of function, 
overall impact, and symptoms. The FIQ-R includes 21 questions that are graded on a 0-10 
numeric scale and higher scores correspond to higher levels of negative impact. Questions are 
framed in the context of the past seven days and include items such as “difficulty in sitting in 
a chair for 45 minutes”, “fibromyalgia prevented me from accomplishing goals for the 
week”, and “please rate the level of pain”. The summed score for the function domain (range 
0 to 90) is divided by three, the summed score for overall impact domain (range 0 to 20) 
remains unchanged, and the summed score for the symptom domain (range 0 to 100) is 
divided by two. The total FIQ-R score is the sum of the three modified domain scores and the 
maximum total score is 100. Based on over 250 studies employing either the FIQ-R or the 
original Fibromyalgia Impact Questionnaire (Burckhardt, Clark, & Bennett, 1991), 
individuals diagnosed with FMS typically score between 55-65 (Bennett et al., 2009). 
Short-form McGill Pain Questionnaire (SF-MPQ; Melzack, 1987): The Pain Perception 
Index of the SF-MPQ comprises 15 sensory or affective pain descriptors (e.g., throbbing, 
aching, heavy, and punishing) that are rated on a four-point Likert scale (0 = none, 3 = 
severe). Scores for each pain descriptor are combined to give a total measure of pain 
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perception. The maximum score is 45 and a mean improvement of more than 5 points is 
deemed to be clinically important (Hawker, Mian, Kendzerska, & French, 2011).  
Depression, Anxiety, and Stress Scale (DASS; Lovibond & Lovibond, 1995): The 21-item 
DASS assesses psychological distress and comprises three sub-scales: (i) depression, (ii) 
anxiety, and (iii) stress. The scale is scored on a four-point Likert scale (from: 0 = Did not 
apply to me at all, to 3 = Applied to me very much or most of the time) and features items 
such as “I found it hard to wind down” and “I felt that life was meaningless”. The DASS is 
completed in respect of the foregoing seven-day period. According to the DASS manual 
(Lovibond & Lovibond, 1995), the percentile cut-offs and corresponding mean scores for 
symptom severity are as follows: 0-78 (M ≤ 13) = normal, 78-87 (M = 14-18) = mild, 87-95 
(M = 19-28) = moderate, and > 95 (M ≥ 28 = severe).  
Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds Monk, Berman, & Kupfer, 1989): 
The seven-item PSQI assesses sleep quality during the past month across the domains of 
subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleep medication, and daytime dysfunction. The PSQI is scored on a 
four-point Likert scale (0 = no difficulty, 3 = extreme difficulty) and features items such as 
“during the past month, how would you rate your sleep quality overall?” The maximum score 
is 21 and a global score of ≥5 indicates a poor quality of sleep (Buysse et al., 1989).  
Non-Attachment Scale (NAS; Sahdra, Shaver, & Brown, 2010; Sahdra, Ciarrochi, Parker, 
Marshall, & Heaven, 2015): The seven-item NAS is based on a Buddhist model of mental 
illness and evaluates the degree to which a person becomes attached to their experiences on 
the psychological, social, and environmental plane. The NAS also assesses the degree to 
which a person is ‘attached to themselves’ because according to Buddhist theory, attachment 
to psychological or environmental phenomena arises due to a firm sense of selfhood (Van 
Gordon, Shonin, & Griffiths, 2016c). The NAS is constructed upon the Buddhist notion that 
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the self does not inherently exist and that attachment to self and environment thus constitutes 
a maladaptive condition (see Shonin et al. [2014a] for a discussion of the differences between 
Buddhist and Western psychological conceptualisations of attachment). The NAS is scored 
on a six-point Likert scale (from 1 = disagree strongly to 6 = agree strongly) and features 
items such as “When pleasant experiences end, I am fine moving on to what comes next”. The 
maximum score is 42 and higher scores reflect lower levels of attachment (or higher levels of 
non-attachment).  
Civic Engagement: Participants were asked to record how many hours during the previous 
seven days they had spent engaging in paid work, voluntary work, participating in an event or 
meeting hosted by a community organisation or group, and/or mentoring another non-family 
member of the community.  
 
Data Analysis 
A significance level of p < 0.05 and two-tailed tests were employed throughout. Independent 
samples t-tests (for continuous variables) and chi-square tests with Yates’s correction (for 
categorical variables) were used to identify any significant differences between groups in 
demographic characteristics or baseline-dependent variable mean scores.  
Mixed effects models (also known as multi-level models, random effects model, and 
hierarchical models) were used to examine the effect of intervention (MAT) and control 
(CBTG) on all six outcome measures (i.e., FIQ-R, SF-MPQ, DASS, PSQI, NAS, and Civic 
Engagement). Mixed effects modelling accounts for shared variance within-participants while 
modelling between-participant differences. The benefits of mixed effects models are well 
established and include reduced assumptions (i.e., homoscedasticity, sphericity, and 
compound symmetry) and greater statistical power over traditional methods (Baguley, 2012a; 
Gelman & Hill, 2007; Quene & van der Berg, 2004; Snijders & Bosker, 1999). Furthermore, 
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mixed effects models adequately account for baseline differences in outcome scores by 
modelling (per participant) the change in outcome measure relative to baseline across all 
measurement periods (i.e., pre-, post-, and follow-up). Prior to model estimation, distributions 
of all outcome variables and random effects residuals were inspected and deemed to be close 
approximations of normality. Using the absolute median deviation method to detect outliers 
(Leys, Ley, Klein, Bernard, & Licata, 2013), no data points were deemed to be extreme in the 
present data set. The RCT was conducted on an ‘intent-to-treat’ basis with missing data at 
end-point substituted using last-observation-carried-forward basis.  
 
Results 
Recruitment and Allocation 
Participant demographic characteristics are summarised in Table 1. A total of 231 individuals 
completed the screening questionnaire and 83 of these were screened-out on the grounds of 
ineligibility. The main reasons for exclusion were (i) currently receiving structured 
psychotherapy (32 individuals), (ii) unable to confirm current diagnosis of FMS (23 
individuals), (iii) recent change in psychopharmacology type or dosage (13 participants), and 
(iv) currently attending meditation or mindfulness classes (8 participants). Of the 148 
remaining participants, 74 were allocated to the intervention group and the same number to 
the control group (see Figure 1). MAT and the control group interventions were each 
delivered in three separate tranches (i.e., approximately 25 participants per tranche). 
 
[Insert Table 1 and Figure 1 about here] 
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Non-Completion, Attendance, and Fidelity of Implementation 
There were no significant differences between MAT and CBTG in the number of participants 
that dropped out of the study prior to completing the intervention (MAT = 20, CBTG = 22). 
There were no significant differences between dropout and completion samples (i.e., 
irrespective of allocation condition) in sex, education, employment status, marital status, and 
ethnicity. However, there was a significant difference for age where the mean dropout and 
completer age were 44.4 years (SD = 8.8) and 47.9 years (SD = 9.6) respectively (t (91) = -
2.19, p = 0.03). The main reasons for non-completion were that the participant: (i) did not 
attend at least seven of the eight weekly sessions (MAT = 10, CBTG = 12), (ii) found the 
intervention to be overly demanding (MAT = 6, CBTG = 6), or (iii) changed medicine or 
commenced structured psychotherapy after baseline assessment (MAT = 3, CBTG = 2). Of 
those participants that attended the post-intervention assessment phase, 9 MAT and 12 CBTG 
participants were lost to follow up. There were no significant differences between allocation 
conditions in participant ratings of the instructor’s levels of planning and motivation. MAT 
participants practiced meditation for an average of 41.11 minutes per day (SD = 15.26).  
 
Demographic and Baseline Characteristics 
There were no significance differences between allocation conditions in baseline 
demographic characteristics (i.e., sex, age, education, employment status, marital status, or 
ethnicity). Likewise, there were no significant differences between MAT and the CBTG 
group in baseline scores on each of the six outcome measures. 
  
Analysis of Outcome Measures 
A separate mixed effects model was estimated for each outcome measure (see Table 2 for 
means and SDs). Each model included Group (control, intervention) and measurement 
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Interval (pre-, post-, follow-up) as fixed effects (i.e., in the form of an interaction predictor 
[Group*Interval]) and Participant (within measurement Interval) as a random effect. This 
allowed a unique regression model (i.e., intercept and slope) to be specified for every 
participant across measurement intervals (see Figure 2 for an exemplar modelling DASS 
scores across measurement intervals). Results from the six estimated mixed effects models 
show an overall strong effect of intervention compared to control for all outcome measures 
(see Table 3 for summaries of each model). More specifically, relative to baseline and 
compared to control, intervention resulted in a (i) 6.24 (at post) and 7.92 (at follow-up) 
greater decrease in FIQ-R score, (ii) 2.01 (at post) and 3.01 (at follow-up) greater decrease in 
SF-MPQ score, (iii) 3.70 (at post) and 4.86 (at follow-up) greater decrease in DASS score, 
(iv) 1.50 (at post) and 2.28 (at follow-up) greater decrease in PSQI score, (v) 2.81 (at post) 
and 3.57 (at follow-up) greater increase in NAS score, and (vi) 1.69 (at post) and 2.05 (at 
follow-up) greater increase in Civic Engagement (see Figure 3 for a breakdown of 
intervention and control group outcome means across measurement intervals). Overall, 
results demonstrate that MAT significantly outperformed CBTG at both post- and follow-up 
assessment phases for all six outcome measures. 
 
[Insert Tables 2 and 3 and Figures 2 and 3 about here] 
 
Intervention Engagement Effects 
A linear model was estimated, regressing the number of minutes meditated per day onto the 
difference between baseline and follow-up for each outcome measure. Results showed 
significant linear relationships between the number of minutes meditated and all outcome 
differences (see Table 4). This suggests that the level of engagement with meditation is a 
good indicator of its effect, as captured by six different outcome measures.  
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[Insert Table 4 about here] 
 
Mediation Analysis 
Several models were estimated to test the mediating effects of the two secondary outcome 
variables (Civic Engagement, NAS) on all primary outcome variables (FIQ-R, SF-MPQ, 
DASS, PSQI). Given the established relationships between IV-DV and IV-M (i.e., paths a 
and c of Figure 4) via the mixed effects models (see Table 3), only path b was inspected for a 
correlation between mediator and DV (Baron & Kenny, 1986). Analysis demonstrated 
significant relationships between each mediator and respective outcome measure (see Table 
5). Having established that all variables were correlated, a comparison between the direct 
(path c) and indirect effects (paths c + b) was undertaken to determine whether the 
relationship between the IV and DV was attenuated by the inclusion of a mediator (M).  
The results showed that Civic Engagement was a partial mediator of treatment effects 
across all outcome measures (FIQ-R, SF-MPQ, DASS, PSAQI). This can be seen in Table 6 
where each IV-DV regression coefficient is reduced (but remains statistically significant) 
when Civic Engagement is introduced into the model. Treating NAS as a mediator resulted in 
partial mediation of treatment effects for DASS and PSQI but close to full mediation (i.e., IV-
DV paths became non-significant with the inclusion of M) for FIQ-R and SF-MPQ (see Table 
6). This suggests that non-attachment to the self and environment is an important mediating 
mechanism in reducing fibromyalgia symptoms.  
 
[Insert Tables 5 and 6 and Figure 4 about here] 
 
Discussion 
In the present study, an RCT compared MAT with a purpose-designed control intervention in 
individuals with FMS. MAT participants demonstrated significant improvements over control 
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group participants in levels of FMS symptomatology, pain perception, sleep quality, 
psychological distress, non-attachment, and civic engagement. The therapeutic gains 
attributed to MAT were maintained (and in some cases slightly augmented) at six-month 
follow-up.  
Approximately one in four MAT participants did not complete the intervention. This 
level of non-completion is consistent with other studies administering meditation-based 
interventions to individuals with FMS where non-completion rates between 21-37% have 
been reported (e.g., Kaplan, Goldenberg, & Galvin-Nadeau, 1993; Mannerkorpi & Arndorw 
2004; Weissbecker, Salmon, Studts, Floyd, Dedert, & Sephton, 2004). However, in the 
present study, only six participants reported that they dropped out because the intervention 
was over-demanding. A more common reason for non-completion was failure to attend at 
least seven of the eight weekly MAT sessions (i.e., ten participants reported that they were 
unable to attend one or more sessions due to unforeseen circumstances). Given that some 
studies investigating the applications of mindfulness for treating FMS have set the requisite 
attendance rate as low as 50% (e.g., Grossman, Schwarzer, Jena, Naumann, & Walach 
(2011), and given that FMS treatment studies typically report relatively high rates of drop-out 
(i.e., when compared to other patient groups), the present authors deem that the non-
completion levels observed here support the acceptability of MAT for the target population 
(i.e., an equivalent level of drop-out observed in an intervention with higher attendance 
requirements suggests that it is relatively more acceptable). Additional support for the 
acceptability of the intervention is derived from the fact that no significant differences in drop 
out were observed across allocation conditions. 
 With the exception of meditative practices and principles, the CBTG control condition 
was designed to replicate MAT on all other intervention design factors (e.g., duration, 
facilitator-participant contact time, group discussion, instructor didactic style, etc.). 
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Compared to a wait list control, treatment-as-usual, or ‘convenience’ comparison 
intervention, the use of a ‘matched’ active control condition allows therapeutic gains due to 
non-specific factors (e.g., group interaction, therapeutic alliance, etc.) to be filtered out. 
Consequently, findings from the present study provide a reliable indicator of the treatment 
effects that can be attributed to the ‘active ingredient’ of MAT (i.e., meditation). The fact that 
therapeutic improvements were due to meditation is further supported by findings from the 
regression analysis that showed average daily time spend meditating was a significant 
predictor of changes in all outcome variables. Designing studies that permit such inferences 
to be made is particularly important for MBIs because such interventions typically employ a 
variety of therapeutic and relaxation techniques.  
 Irrespective of allocation condition, a slight but statistically significant age difference 
was observed in the present study between completers and non-completers. The fact that non-
completers were slightly older that completers (mean age of 47.9 and 44.4 years, 
respectively) could suggest that the acceptability of both MAT and CBTG is reduced in 
slightly older FMS populations. However, both the age difference and non-completion 
sample size are too small to draw reliable conclusions in this respect. Furthermore, this 
finding has not been observed in other studies of MAT or – to the best of the present authors’ 
knowledge – in other MBI studies involving individuals with FMS. Nevertheless, future FMS 
treatment studies using MBIs could seek to investigate this finding further. 
The improvements experienced by participants across all primary outcome measures 
(i.e., fibromyalgia symptomatology, pain perception, psychological distress, and sleep 
quality) are largely consistent with FG-MBI studies involving individuals with FMS (e.g., 
Davis & Zautra, 2013; Henke & Chur-Hansen, 2014; Lauche et al., 2013). However, based 
on a single SG-MBI study, it is difficult to draw reliable conclusions as to the comparative 
effectiveness of SG-MBIs and FG-MBIs for individuals with FMS. Reliably formulating such 
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conclusions would require further controlled large-sample FMS treatment studies using SG-
MBIs and/or several purpose designed head-to-head studies. Data on which particular MBI is 
most effective for FMS (or a given medical illness) is certainly of value to the medical 
community. However, rather than seek to out-perform or replace FG-MBIs, the primary 
intent underlying the SG-MBI initiative appears to be that of providing service users with a 
greater choice of evidence-based mindfulness intervention – including that of practicing 
mindfulness in a manner that is more consistent with the traditional spiritual 
conceptualisation of the technique (Van Gordon, Shonin, Lomas, & Griffiths, 2016d)  
Notwithstanding the consistency between findings from primary outcome measures in 
the present study and those from FMS treatment studies using FG-MBIs, a qualitative 
feasibility study that was embedded within the present RCT (i.e., Van Gordon et al., 2016a) 
reported outcomes that are not typically associated with FG-MBIs. More specifically, 
analysis of interview transcripts from ten MAT participants that were randomly allocated to a 
qualitative arm yielded a master theme of spiritual growth. This theme is consistent with 
outcomes from the mediation analysis which showed that non-attachment to self almost fully 
mediated the treatment effects for FMS symptomatology and pain perception. In Buddhism, 
‘spiritual growth’ and ‘reductions in attachment’ are arguably synonymous terms because 
according to the Buddhist conceptualisation, a practice can be deemed spiritual if it helps to 
transcend ‘selfhood’ (Van Gordon et al., 2016d).  
The abovementioned qualitative study also reported a theme of increased willingness 
to civically engage that participants attributed to greater spiritual awareness as well as a 
reduced emphasis on their own suffering and life problems (Van Gordon et al., 2016a). This 
is consistent with the finding in the current study of civic engagement partially meditating the 
treatment effects for all outcome variables. Being more ‘other-centered’ improves life 
perspective and dismantles self-obsessed and self-disparaging cognitive schemas (Shonin, 
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Van Gordon, Compare, Zangeneh, & Griffiths, 2015a). Furthermore, a compassionate 
disposition and spiritual outlook has been shown to increase social-connectedness and 
prosocial behaviour (Hutcherson, Seppala, & Gross, 2008; Leiberg, Olga, & Tania, 2011). 
Thus, viewing the findings of this and the embedded qualitative study as a collective, it seems 
reasonable to conclude that a meditation-induced growth in spirituality played an important 
mechanistic role in improving both primary and secondary outcomes.  
 Key limitations of the study were reliance on self-report measures and the fact that 
outcomes were only assessed at three time points (i.e., pre-, post-, and six-month follow-up). 
An increased number of assessment phases would provide insights on which particular stages 
of the eight-week intervention have the strongest treatment effects. Furthermore, an 
assessment beyond the six-month stage would provide a better indication of maintenance 
effects as well as the need for booster sessions. A further factor that may limit findings is a 
phenomenon that has been termed the ‘popularity effect’ (Shonin, Van Gordon, & Griffiths, 
2015b). Mindfulness and meditation are experiencing growing popularity amongst both the 
scientific community and general public. Consequently, outcomes of both FG-MBI and SG-
MBI studies could be influenced by participants’ belief that they are receiving a ‘fashionable’ 
and/or ‘proven’ psychotherapeutic technique (Shonin et al., 2015b). This is a difficult 
confounding factor to control for because it is almost impossible to blind participants from 
the fact they are undergoing mindfulness training. Finally, although GPs and other health 
professionals assisted in raising awareness of the study, interested participants were required 
to contact the research team directly in order to be considered for recruitment. Thus, 
participants in the present study were effectively ‘self-referring’ and it is difficult to gauge 
whether outcomes would be as favourable for individuals directly referred by their GP or 
another health professional. 
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 The present study suggests that MAT is an effective FMS treatment and contributes 
further evidence supporting the applications of SG-MBIs in clinical and other applied 
settings. The considerable focus on the ‘self’ by some individuals with FMS means that SG-
MBIs (that place emphasis on reducing attachment to self) may be particularly suitable 
treatments for this population group. Further controlled empirical studies using large sample 
sizes are therefore warranted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
References 
Baguley, T. (2012a). Serious stats: A guide to advanced statistics for the behavioral 
sciences. Basingstoke: Palgrave Macmillan. 
Baguley, T. (2012b). Calculating and graphing within-subject confidence intervals for 
ANOVA. Behavior Research Methods, 44, 158-175. 
Baron, R., & Kenny, D. (1986). The moderator–mediator variable distinction in social 
psychological research: Conceptual, strategic, and statistical considerations. Journal of 
Personality and Social Psychology, 51, 1173-1182. 
Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009). The 
Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric 
properties. Arthritis Research and Theory, 11, R120. 
Boutron, I., Altman, D. G., Schulz, K. F., & Ravaud, P. (2008). Extending the CONSORT 
statement to randomized trials of nonpharmacologic treatment: Explanation and 
elaboration. Annals of Internal Medicine, 148, 295-309. 
Branco, J. C., Bannwarth, B., Failde, I., Abello Carbonell, J., Blotman, F., Spaeth, M., … 
Matucci-Cerinic, M. (2010). Prevalence of fibromyalgia: A survey in five European 
countries. Seminars in Arthritis and Rheumatism, 39, 448-55. 
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The 
Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and 
practice. Psychiatry Research, 28, 193-213. 
 
 
25 
 
Canzonieri, A. M., Pollak, D. F., Oliveira, P. J., Costa, M. E., & Natour, J. (2013). Evaluation 
of socio-demographic variables, psychiatric comorbidity, and pain in fibromyalgia 
patients. Annals of Rheumatic Disorders, 71, 756. 
Davis, M. C., & Zautra, A. J. (2013). An online mindfulness intervention targeting 
socioemotional regulation in fibromyalgia: results of a randomized controlled trial. Annals 
of Behavioural Medicine, 46, 273-284 
Faul. F., & Erdinger, E. (1992). GPOWER: A priori, post-hoc, and compromise power 
analysis for MS-DOS. Bonn University. 
Feliu-Soler, A., Soler, J., Luciano, J. V., Cebolla, A., Elices, M., Demarzo, M., & García-
Campayo, J. (2016). Psychometric properties of the Spanish version of the Non-
Attachment Scale (NAS) and its relationship with mindfulness, decentering and mental 
health. Mindfulness, 7, 1156–1169. 
Garcia-Martin, E., Ruiz-de-Gopegui, E., Otin, S., Blasco, A., Larrosa, J. M., Polo, V., … 
Garcia-Campayo, J. (2016). Assessment of visual function and structural retinal changes 
in zen meditators: Potential effect of mindfulness on visual ability. Mindfulness, 7, 979–
987 
Gelman, A., & Hill, J., (2007). Data analysis using regression and multilevel/hierarchical 
model. Cambridge: Cambridge University Press. 
Glombiewski, J. A, Sawyer, A.T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S.G 
(2010). Psychological treatments for fibromyalgia: A meta-analysis. Pain, 151, 280-295. 
Goyal, M., Singh, S., Sibinga, E. M., Gould, N. F., Rowland-Seymour, A., Sharma, R., … 
Haythornthwaite, J. A. (2014). Meditation programs for psychological stress and well-
being: A systematic review and meta-analysis. JAMA Internal Medicine, 174, 357-368. 
 
 
26 
 
Grossman, P., Schwarzer, B., Jena, S., Naumann, J., & Walach, H. (2011). Treating 
fibromyalgia with mindfulness-based stress reduction: Results from a 3-armed randomized 
controlled trial. Pain, 152, 361-369. 
Häuser, W., Wolfe, F., Tölle, T., Üçeyler, N., & Sommer, C. (2012). The role of 
antidepressants in the management of fibromyalgia syndrome: A systematic review and 
meta-analysis. CNS Drugs, 26, 297-307. 
Henke, M., & Chur-Hansen, A. (2014). The effectiveness of mindfulness-based programs on 
physical symptoms and psychological distress in patients with fibromyalgia: A systematic 
review. International Journal of Wellbeing, 4, 28-45. 
Hutcherson, C. A., Seppala, E. M., & Gross, J. J. (2008). Loving-kindness meditation 
increases social connectedness. Emotion, 8, 720-724. 
Jones, K. D., Sherman, C. A., Mist, S. D., Carson, J. W., Bennett, R. M., & Li, F. (2012). A 
randomized controlled trial of 8-form Tai chi improves symptoms and functional mobility 
in fibromyalgia patients. Clinical Rheumatology, 31, 1205-1214. 
Kabat-Zinn, J. (1990). Full Catastrophe Living: Using the wisdom of your body and mind to 
face stress, pain and illness. New York: Delacourt. 
Kabat-Zinn, J. (1994). Wherever you go, there you are: Mindfulness meditation in everyday 
life. New York: Hyperion. 
Kaplan, K. H., Goldenberg, D. L., & Galvin-Nadeau, M. (1993). The impact of a meditation-
based stress reduction program on fibromyalgia. General Hospital Psychiatry, 15, 284-
289. 
Langhorst, J., Klose, P., Dobos, G. J., Bernardy, K, & Häuser, W. (2013). Efficacy and safety 
of meditative movement therapies in fibromyalgia syndrome: A systematic review and 
meta-analysis of randomized controlled trials. Rheumatology International, 33, 193-207. 
 
 
27 
 
Lauche, R., Cramer, H., Dobos, G., Langhorst, J., & Schmidt, S. (2013). A systematic review 
and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. 
Journal of Psychosomatic Research, 75, 500-510. 
Leiberg, S., Klimecki, O., & Singer, T. (2011). Short-term compassion training increases 
prosocial behavior in a newly developed prosocial game. PLoS ONE, 6(3), e17798. 
Leys, C., Ley, C., Klein, O., Bernard, P., & Licata, L., (2013). Detecting outliers: Do not use 
standard deviation around the mean, use absolute deviation around the median. Journal of 
Experimental Social Psychology, 49, 764-766. 
Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the depression anxiety stress scales. 
Sydney: Psychology Foundation.  
Luciano, J. V., Guallar, J., A., Aguado, J., López-del-Hoyo, Y., Olivan, B., Magallón, R., … 
Garcia-Campayo, J. (2014). Effectiveness of group acceptance and commitment therapy 
for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study). Pain, 155, 
693-702. 
MacCoon, D. G., Imel, Z. E., Rosenkranz, M. A., Sheftel, J. G., Weng, H. Y., Sullivan, J. C., 
… Lutz, A. 2012. The validation of an active control intervention for Mindfulness Based 
Stress Reduction (MBSR). Behaviour Research and Therapy, 50, 3-12. 
Mannerkorpi, K., & Arndorw, M. (2004). Efficacy and feasibility of a combination of body 
awareness therapy and qigong in patients with fibromyalgia: A pilot study. Journal of 
Rehabilitative Medicine, 36, 279-281. 
Mease, P. J., Arnold, L. M., Crofford, L. J., Williams, D. A., Russell, I. J., Humphrey, L., … 
Martin, S. A. (2008). Identifying the clinical domains of fibromyalgia: Contributions from 
clinician and patient delphi exercises. Arthritis Care and Research, 59, 952-960. 
Melzack, R. (1987). The Short-form McGill Pain Questionnaire. Pain, 30, 191-197. 
 
 
28 
 
Modrego, M., Morillo, H., López Montoyo, A., Correa, M., Borao, L., & García-Campayo, J. 
(2016). Mindfulness levels in patients with fibromyalgia following recommended 
pharmacological treatment: A multicenter, uncontrolled, one-year follow-up study.  
Mindfulness and Compassion, 1, 13-21. 
Moreira-Almeida, A., & Koenig, H. G. (2008). Religiousness and spirituality in fibromyalgia 
and chronic pain patients. Current Pain and Headache Reports, 12, 327-332. 
Morone, N. E., Lynch, C. S., Greco, C. M., Tindle, H. A., & Weiner, D. K. (2008). "I felt like 
a new person." The effects of mindfulness meditation on older adults with chronic pain: 
Qualitative narrative analysis of diary entries. Journal of Pain, 9, 841-848. 
Nüesch, E., Häuser, W., Bernardy, K., Barth, J., & Jüni, P. (2013). Comparative efficacy of 
pharmacological and non-pharmacological interventions in fibromyalgia syndrome: 
network meta-analysis. Annals of the Rheumatic Diseases, 72, 955-962.  
Purser, R. E. (2015). Clearing the muddled path of traditional and contemporary mindfulness: 
A response to Monteiro, Musten, and Compson. Mindfulness, 6, 23-45. 
Quené, H., & van den Bergh, H. (2004). On multi‐level modelling of data from repeated 
measures designs: A tutorial. Speech Communication, 43, 103‐121. 
Sahdra, B. K., Shaver, P. R., & Brown, K. W. (2010). A scale to measure non-attachment: A 
Buddhist complement to Western research on attachment and adaptive functioning. 
Journal of Personality Assessment, 92, 116-127.  
Sahdra, B. K., Ciarrochi, J., Parker, P. D., Marshall, S., & Heaven, P. (2015). Empathy and 
nonattachment independently predict peer nominations of prosocial behavior of 
adolescents. Frontiers in Psychology, 6, 263. 
Schaefer, C., Chandran, A., Hufstader, M., Baik, R., McNett, M., Goldenberg, D., … Zlateva, 
G. (2011). The comparative burden of mild, moderate and severe fibromyalgia: results 
from a cross-sectional survey in the United States. Health Quality of Life Outcomes, 9, 71.  
 
 
29 
 
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated 
guidelines for reporting parallel group randomized trials. Annals of Internal Medicine, 
152, 1-8. 
Segal, Z. V., Williams, J. M., & Teasdale, J. D. (2002). Mindfulness-based cognitive therapy 
for depression: A new approach to preventing relapse. New York: Guilford. 
Shonin, E., & Van Gordon, W. (2015). Managers’ experiences of Meditation Awareness 
Training. Mindfulness, 4, 899-909. 
Shonin, E., Van Gordon W., & Griffiths, M. D. (2014a). The emerging role of Buddhism in 
clinical psychology: Toward effective integration. Psychology of Religion and Spirituality, 
6, 123-137. 
Shonin, E., Van Gordon W., & Griffiths M. D. (2014b). Meditation Awareness Training 
(MAT) for improved psychological wellbeing: A qualitative examination of participant 
experiences. Journal of Religion and Health, 53, 849-863. 
Shonin, E., Van Gordon, W., Dunn, T., Singh, N., & Griffiths, M. D. (2014c). Meditation 
Awareness Training for work-related wellbeing and job performance: A randomized 
controlled trial. International Journal of Mental Health and Addiction, 12, 806-823. 
Shonin, E., Van Gordon, W., Compare, A., Zangeneh, M., & Griffiths, M. D. (2015a). 
Buddhist-derived loving-kindness and compassion meditation for the treatment of 
psychopathology: A systematic review. Mindfulness, 6, 1161-1180. 
Shonin, E., Van Gordon, W., & Griffiths, M. D. (2015b). Does mindfulness work? British 
Medical Journal, 351:h6919. doi: 10.1136/bmj.h6919. 
Sicras-Mainar, A., Rejas, J., Navarro, R., Blanca, M., Morcillo, A., Larios, R., … Villarroya, 
C. (2009). Treating patients with fibromyalgia in primary care settings under routine 
medical practice: a claim database cost and burden of illness study. Arthritis Research & 
Therapy, 11, R54. doi:10.1186/ar2673.  
 
 
30 
 
Snijders, T. A. B., & Bosker, R. J., (1999). Multilevel analysis: An introduction to basic and 
advanced multilevel Modelling. London: Sage. 
Van Gordon, W., Shonin, E., Sumich, A., Sundin, E., & Griffiths, M. D. (2014). Meditation 
Awareness Training (MAT) for psychological wellbeing in a sub-clinical sample of 
university students: A controlled pilot study. Mindfulness, 5, 381-391. 
Van Gordon, W., Shonin, E., & Griffiths, M. D. (2015). Towards a second-generation of 
mindfulness-based interventions. Australia and New Zealand Journal of Psychiatry, 49, 
591-591. 
Van Gordon, W., Shonin, E., & Griffiths, M. D. (2016a). Meditation Awareness Training for 
individuals with fibromyalgia syndrome: An interpretative phenomenological analysis of 
participant’s experiences. Mindfulness, 7, 490-419.  
Van Gordon, W., Shonin, E., & Griffiths, M. D. (2016b). Meditation Awareness Training for 
the treatment of sex addiction: A case study. Journal of Behavioral Addiction, 5, 363-372.  
Van Gordon, W., Shonin, E., & Griffiths, M. D. (2016c). Ontological addiction: 
Classification, etiology, and treatment. Mindfulness, 7, 660-671.  
Van Gordon, W., Shonin, E., Lomas, T., & Griffiths, M. D. (2016d). Corporate use of 
mindfulness and authentic spiritual transmission: Competing or compatible ideals? 
Mindfulness and Compassion. Advance Online Publication, doi: 
10.1016/j.mincom.2016.10.005. 
Weissbecker, I., Salmon, P., Studts, J. L., Floyd, A. R., Dedert, E. A., & Sephton, A. E. 
(2004). Mindfulness-based stress reduction and sense of coherence among women with 
fibromyalgia. Journal of Clinical Psychology in Medical Settings, 9, 297-308. 
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., … 
Yunus, M. B. (1997). Work and disability status of persons with fibromyalgia. Journal of 
Rheumatology, 24, 1171-1178. 
 
 
31 
 
Wolfe, F. (2009). Fibromyalgia wars. Journal of Rheumatology, 36, 671-678.  
Wolfe, F., Brähler, E., Hinz, A., & Häuser, W. (2013). Fibromyalgia prevalence, somatic 
symptom reporting, and the dimensionality of polysymptomatic distress: Results from a 
survey of the general population. Arthritis Care and Research, 65, 777-785. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Table 1. Baseline demographic characteristics for each allocation condition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic MAT (n = 74) CBTG (n = 74) 
Age, mean (SD) 46.41 (9.06) 47.34 (9.83) 
Female (%) 82.4 83.8 
Employed (%) 52.70 48.65 
Education (%)   
School Leaver 55.41 59.46 
Vocational 25.68 25.68 
University 18.92 14.87 
Marital Status (%)   
Married 56.76 63.51 
Single 9.46 5.41 
Divorced 27.03 24.32 
Widow 6.76 6.76 
Ethnicity (%)   
White (British) 77.03 71.62 
White (Non-British) 9.46 9.46 
Asian 8.11 9.46 
Black (Caribbean) 5.3 9.46 
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Table 2.  Means and standard deviations of outcome variable scores for group and time 
  FIQ-R  SF-MPQ  DASS  PSQI  NAS  Civic 
Engagement 
 Group Mean SD  Mean SD  Mean SD  Mean SD  Mean SD  Mean SD 
                   
Pre  Intervention 55.24 10.06  28.04 4.64  26.61 5.33  14.11 2.43  18.45 4.11  17.24 11.62 
 Control 54.04 8.86  27.58 3.69  26.24 4.19  14.09 2.35  18.28 3.70  17.78 12.23 
Post Intervention 46.89 9.55  24.82 4.56  21.82 5.02  11.91 2.71  22.14 4.68  19.35 11.95 
 Control 51.93 8.80  26.38 3.75  25.16 4.11  13.39 2.53  19.16 3.92  18.20 11.83 
Follow-up Intervention 45.65 10.95  23.84 5.38  20.65 5.96  11.36 3.09  22.78 5.39  19.85 11.80 
 Control 52.36 9.29  26.39 3.93  25.15 4.58  13.64 2.55  19.05 3.78  18.34 12.23 
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Table 3. Fixed effects estimates (at post and follow-up assessment phases) with 95% CIs for 
all six outcome measures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: The reference category in all cases is the control group. This means a Post FIQ-R score 
of -6.24 can be interpreted as a -6.24 change in FIQ-R score in comparison to the control 
condition relative to baseline (i.e., Pre FIQ-R score). 
 
  
value  
 
CIs 
 
t-value 
 
p-value 
FIQ-R     
(Intercept) 54.04    
Post  -6.24 -8.24:-4.25 -6.13 <0.001 
Follow-up -7.92 -13.76:-7.76 -6.14 <0.001 
SF-MPQ     
(Intercept) 27.58    
Post  -2.01 -2.80:-1.26 -5.24 <0.001 
Follow-up  -3.01 -4.09:-1.94 -5.48 <0.001 
DASS     
(Intercept) 26.24    
Post -3.70 -4.77:-2.63 -6.80 <0.001 
Follow-up -4.86 -6.30:-3.43 -6.63 <0.001 
PSQI     
(Intercept) 14.09    
Post  -1.50 -2.03:-0.96 -5.53 <0.001 
Follow-up   -2.28 -2.94:-1.63 -6.83 <0.001 
NAS     
(Intercept) 18.28    
Post 2.81 1.92:3.70 6.17 <0.001 
Follow-up 3.57 2.50:4.63 6.56 <0.001 
Civic Engagement     
(Intercept) 17.78    
Post  1.69 0.53:2.84 2.86 <0.01 
Follow-up  2.05 1.10:3.00 4.24 <0.001 
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Table 4. Parameter estimates of linear models for minutes meditated and outcome measures 
Outcome measures Intercept Estimate SE t-value p-value 
FIQ-R 7.59 -0.50 0.06 -8.05 <0.001 
SF-MPQ 0.82 -0.16 0.03 -5.53 <0.001 
DASS 3.17 -0.28 0.03 -8.28 <0.001 
PSQI 0.72 -0.11 0.02 -6.71 <0.001 
NAS -2.87 0.21 0.02  9.20 <0.001 
Civic Engagement 0.05 0.09 0.03  2.59 <0.05 
Note: All outcome measure differences (baseline – follow-up) are predicted by the number of 
average minutes meditated per day  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Table 5. Parameter estimates of path b treating the potential mediator as a predictor of each 
outcome measure 
 Intercept Estimate SE t-value p-value 
Civic 
Engagement  
     
FIQ-R  -2.66 -1.87 0.17 -10.80 <0.001 
SF-MPQ -1.55 -0.72 0.07 -9.44 <0.001 
DASS -1.85 -1.06 0.10 -10.35 <0.001 
PSQI  -0.93 -0.42 0.05 -8.33 <0.001 
NAS       
FIQ-R  -0.27 -2.10 0.08 -24.60 <0.001 
SF-MPQ -0.69 -0.78 0.04 -16.30 <0.001 
DASS  -0.58 -1.15 0.05 -19.62 <0.001 
PSQI  -0.30 -0.50 0.02 -17.11 <0.001 
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Table 6. Parameter estimates for mediation models with Civic Engagement and NAS as separate mediators of all primary outcome variables 
(FIQ-R, SF-MPQ, DASS, PSQI) 
 
 
 
 
 
 
 
 
 
Note: Step 1 = direct effect (DV~IV), Step 2 = indirect effect (DV~IV+M) [‘~’=predicted by] 
Sig. level: ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 
  
  FIQ-R  SF-MPQ  DASS  PSQI 
  Step1 Step2  Step1 Step2  Step1 Step2  Step1 Step2 
Intercept 
 
-1.67 -0.77  -1.19 -0.84  -1.09 -0.59  -0.45 -0.27 
b (IV) 
b (Civic Eng.) 
 
-7.92*** -4.56***  
-1.63*** 
 -3.01*** 
 
-1.71*** 
-0.63*** 
 -4.86*** -3.01*** 
-0.89*** 
 -2.28*** -1.58*** 
-0.33*** 
F change 
 
87.84***   65.44***   79.18***   46.49***  
 
 
0.21 0.51  0.17 0.42  0.23 0.50  0.24 0.42 
Intercept 
 
-1.67 -0.08  -1.18 -0.59  -1.09 -0.25  -0.45 -0.09 
b (IV) 
b (NAS) 
 
-7.91*** -0.55 
-2.06*** 
 -3.01*** -0.27 
-0.76*** 
 -4.86*** -0.97* 
-1.08*** 
 -2.28*** -0.61* 
-0.46*** 
F change 
 
450.50***   195.42***   271.21***   199.3***  
 
 
0.20 0.80  0.17 0.64  0.23 0.73  0.24 0.68 
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Figure 1.  Flow of participants through recruitment and assessment phases. 
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Figure 2. Mixed effect model for DASS 
 
Note: The plot shows each participant’s DASS score trajectory across measurement intervals 
(pre, post, follow-up). Narrow lines illustrate trajectories at the subject-level whereas two 
fuller lines illustrate the predicted population estimates by group (control vs. intervention). 
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Figure 3. Outcome means (intervention and control) across measurement intervals with two-
tier 95% CIs. 
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Note: The inner tier of a two-tiered CI represents CIs for the mean whilst the outer tier 
represents a difference-adjusted CI. Difference-adjusted CIs represent the individual means 
but calibrates the CI to indicate whether the sample means differ (using 95% confidence in 
the difference as a standard) (Baguley, 2012b).  
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Figure 4. Example of mediation model paths 
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